229 related articles for article (PubMed ID: 25427930)
1. Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defect.
Mohamed I; Ethier G; Goyer I; Major P; Dahdah N
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25427930
[TBL] [Abstract][Full Text] [Related]
2. Transposition of the great arteries, pulmonary atresia, and multiple ventricular septal defects associated with multiple cardiac rhabdomyomas in a case of tuberous sclerosis.
Jiang ZY; Pircova A; Sekarski N; Hack I; Laurini R; Janzer R; Payot M
Pediatr Cardiol; 2000; 21(2):165-9. PubMed ID: 10754091
[TBL] [Abstract][Full Text] [Related]
3. Accelerated Cardiac Rhabdomyoma Regression with Everolimus in Infants with Tuberous Sclerosis Complex.
Aw F; Goyer I; Raboisson MJ; Boutin C; Major P; Dahdah N
Pediatr Cardiol; 2017 Feb; 38(2):394-400. PubMed ID: 27878332
[TBL] [Abstract][Full Text] [Related]
4. Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus.
Doğan V; Yeşil Ş; Kayalı Ş; Beken S; Özgür S; Ertuğrul İ; Bozkurt C; Örün UA; Karademir S
J Trop Pediatr; 2015 Feb; 61(1):74-7. PubMed ID: 25344617
[TBL] [Abstract][Full Text] [Related]
5. Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial.
Stelmaszewski EV; Parente DB; Farina A; Stein A; Gutierrez A; Raquelo-Menegassio AF; Manterola C; de Sousa CF; Victor C; Maki D; Morón EM; de Abrantes FF; Iqbal F; Camacho-Vilchez J; Jimenez-Pavón J; Polania JP; Thompson L; Bonanato L; Diebold M; Da Silva MVCP; Nashwan MWJ; Galvani MAG; Idris OEA; Danos P; Ortiz-Lopez R; Mahmoud RAA; Gresse S; Loss KL
Cardiol Young; 2020 Mar; 30(3):337-345. PubMed ID: 31983379
[TBL] [Abstract][Full Text] [Related]
6. Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex.
Colaneri M; Quarti A; Pozzi M
Cardiol Young; 2016 Jun; 26(5):1025-8. PubMed ID: 27055516
[TBL] [Abstract][Full Text] [Related]
7. Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia.
Öztunç F; Atik SU; Güneş AO
Cardiol Young; 2015 Oct; 25(7):1411-4. PubMed ID: 26339757
[TBL] [Abstract][Full Text] [Related]
8. Giant left ventricular rhabdomyoma treated successfully with everolimus: case report and review of literature.
Martínez-García A; Michel-Macías C; Cordero-González G; Escamilla-Sánchez KI; Aguinaga-Ríos M; Coronado-Zarco A; Cardona-Pérez JA
Cardiol Young; 2018 Jul; 28(7):903-909. PubMed ID: 29759095
[TBL] [Abstract][Full Text] [Related]
9. Regression of a cardiac rhabdomyoma in a patient receiving everolimus.
Tiberio D; Franz DN; Phillips JR
Pediatrics; 2011 May; 127(5):e1335-7. PubMed ID: 21464184
[TBL] [Abstract][Full Text] [Related]
10. Rapid resolution of cardiac rhabdomyomas following everolimus therapy.
Choudhry S; Nguyen HH; Anwar S
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26661560
[TBL] [Abstract][Full Text] [Related]
11. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma.
Davis KA; Dodeja AK; Clark A; Hor K; Baker P; Cripe LH; Cripe TP
Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31088894
[TBL] [Abstract][Full Text] [Related]
12. Rapid regression of left ventricular outflow tract rhabdomyoma after sirolimus therapy.
Breathnach C; Pears J; Franklin O; Webb D; McMahon CJ
Pediatrics; 2014 Oct; 134(4):e1199-202. PubMed ID: 25180276
[TBL] [Abstract][Full Text] [Related]
13. Rapid response of a cardiac rhabdomyoma causing severe right ventricular outflow obstruction to Sirolimus in an infant with negative genetics for Tuberous sclerosis.
Nir-David Y; Brosilow S; Khoury A
Cardiol Young; 2021 Feb; 31(2):312-314. PubMed ID: 33148352
[TBL] [Abstract][Full Text] [Related]
14. Everolimus for severe arrhythmias in tuberous sclerosis complex related cardiac rhabdomyomas.
Silva-Sánchez MP; Alvarado-Socarras JL; Castro-Monsalve J; Meneses KM; Santiago J; Prada CE
Am J Med Genet A; 2021 May; 185(5):1525-1531. PubMed ID: 33590972
[TBL] [Abstract][Full Text] [Related]
15. Rapid Involution of Large Cardiac Rhabdomyomas With Everolimus Therapy.
Garg A; Gorla SR; Kardon RE; Swaminathan S
World J Pediatr Congenit Heart Surg; 2021 May; 12(3):426-429. PubMed ID: 31072227
[TBL] [Abstract][Full Text] [Related]
16. Rapid regression of large cardiac rhabdomyomas in neonates after sirolimus therapy.
Weiland MD; Bonello K; Hill KD
Cardiol Young; 2018 Mar; 28(3):485-489. PubMed ID: 29233209
[TBL] [Abstract][Full Text] [Related]
17. Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate-Rapid Tumor Regression Documented by Real Time 3D Echocardiography.
Wagner R; Riede FT; Seki H; Hornemann F; Syrbe S; Daehnert I; Weidenbach M
Echocardiography; 2015 Dec; 32(12):1876-9. PubMed ID: 26199144
[TBL] [Abstract][Full Text] [Related]
18. Everolimus for the Treatment of Tuberous Sclerosis Complex-Related Cardiac Rhabdomyomas in Pediatric Patients.
Dahdah N
J Pediatr; 2017 Nov; 190():21-26.e7. PubMed ID: 28888564
[No Abstract] [Full Text] [Related]
19. Neonatal rhabdomyoma with cardiac dysfunction: favourable response to sirolimus.
Duan M; Sundararaghavan S; Koh AL; Soh SY
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35332001
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis with cardiac rhabdomyoma manifested by fetal bradycardia: report of a case.
Jan CJ; Wu FF; Sue WC; Chang CH; Lin YH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1991; 32(3):183-90. PubMed ID: 1776443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]